TMEM104: A Transmembrane Protein for Drug Targets and Biomarkers

Target Name: TMEM104

NCBI ID: G54868

TMEM104

TMEM104: A Transmembrane Protein for Drug Targets and Biomarkers

TMEM104 (Transmembrane protein 104) is a protein that has been identified as a potential drug target and biomarker. It is a member of the TMEM family, which is known for its role in cell signaling and membrane transport. TMEM104 is expressed in various tissues and cell types and has been shown to play a role in several cellular processes, including cell signaling, cell adhesion, and cell survival.

Drug Target Potential

TMEM104 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of the key reasons for its potential as a drug target is its transmembrane nature, which allows it to interact with various signaling molecules on the surface of the cell. Additionally, TMEM104 has been shown to play a role in several cellular signaling pathways, including the TGF-β pathway. This pathway is involved in cell growth, differentiation, and survival, and is a potential target for drugs that are aimed at preventing or reversing these processes.

TMEM104 has also been shown to interact with several signaling molecules on the surface of the cell, including TGF-β1, FGF, and PDGF. These molecules are involved in cell signaling and growth, and are potential targets for drugs that are aimed at inhibiting these processes. TMEM104 has also been shown to play a role in regulating the actinin cytoskeleton, which is involved in cell adhesion and stability.

Biomarker Potential

In addition to its potential as a drug target, TMEM104 has also been identified as a potential biomarker. Its involvement in several cellular processes, including cell signaling and cell adhesion, makes it a potential marker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

TMEM104 has been shown to be involved in several signaling pathways that are involved in the development and progression of these diseases. For example, TMEM104 has been shown to be involved in the development and progression of cancer, as well as neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Additionally, TMEM104 has been shown to be involved in autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

Conclusion

TMEM104 is a protein that has been identified as a potential drug target and biomarker. Its transmembrane nature and its involvement in various cellular processes make it a promising target for drugs that are aimed at inhibiting or reversing these processes. Additionally, TMEM104 has been shown to be involved in several signaling pathways that are involved in the development and progression of several diseases, making it a potential biomarker for these conditions. Further research is needed to fully understand the role of TMEM104 as a drug target and biomarker, and to develop effective treatments for these conditions.

Protein Name: Transmembrane Protein 104

The "TMEM104 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM104 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets